2019
DOI: 10.1097/rli.0000000000000577
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T

Abstract: The relaxivities of 3 macrocyclic gadolinium-based contrast agents (GBCAs) were determined in human plasma and blood under standardized and clinically relevant laboratory conditions. Methods: The T1 relaxivity, r1, was determined in human plasma at 1.5, 3, and 7 T, and in human blood at 3 T at 37°C in phantoms containing 4 different concentrations of the macrocyclic GBCAs gadobutrol, gadoteridol, and gadoterate. An inversion recovery turbo spin echo sequence was used to generate images with several inversion t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
44
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 48 publications
(46 citation statements)
references
References 34 publications
2
44
0
Order By: Relevance
“…When we plotted SI against the dilution of the GBCA formulations (right columns of Figs. 3 and 4), the SI differences were due to two features: (i) the different relaxivities of the GBCAs (14); and (ii) the different concentrations of the formulations in what is meant to reflect first-pass bolus imaging, as in angiography. As gadobutrol is formulated as a 1 molar and the two other GBCAs as 0.5 molar solutions, the SI differences were more pronounced in the dilution experiments.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…When we plotted SI against the dilution of the GBCA formulations (right columns of Figs. 3 and 4), the SI differences were due to two features: (i) the different relaxivities of the GBCAs (14); and (ii) the different concentrations of the formulations in what is meant to reflect first-pass bolus imaging, as in angiography. As gadobutrol is formulated as a 1 molar and the two other GBCAs as 0.5 molar solutions, the SI differences were more pronounced in the dilution experiments.…”
Section: Discussionmentioning
confidence: 99%
“…(13) and published by Szomolanyi et al. (14). However, here we focus on SI enhancement, a more clinically tangible parameter than relaxivity.…”
Section: Introductionmentioning
confidence: 91%
“…To date, there is no standard protocol for how to best design and analyze a relaxivity experiment . Similar problems have been addressed previously in UV‐Vis spectroscopy and liquid chromatography‐mass spectrometry (LC‐MS) through weighted least squares (WLS), which has also been applied on occasion to relaxivity . Although WLS is a potential solution, the GGLM approach proposed in this work is more flexible as it assigns weights empirically by an iterative reweighted least squares algorithm .…”
Section: Introductionmentioning
confidence: 88%
“…Compared to traditional MRI imaging based on T 1 ‐ or T 2 ‐weighted signal intensity, MRI relaxometry is more robust for quantitative comparison as it is less sensitive to nuisance parameters such as coil positioning or scanner variabilities . Among other applications, relaxometry has been used to detect brain abnormalities and myocardial fibrosis or evaluate metabolic imaging, liver iron content (LIC), and contrast agent (CA) properties …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation